A specialty pharmaceutical company focused on developing, manufacturing, and marketing branded and generic drugs across areas such as dermatology, gastroenterology, and eye health through its Bausch + Lomb division. The business historically relied on acquisitions to expand its portfolio and global ...
This page tracks all publicly disclosed congressional trades in Valeant Pharmaceuticals International, Inc. (VRX), a company in the Healthcare sector. 2 members of Congress have disclosed trades in this stock, including 2 purchases and 1 sale. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-02-19 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2014-05-07 | Susan M Collins | sell | $1K – $15K |
| 2014-03-11 | Susan M Collins | buy | $1K – $15K |